Scientific article
English

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy

Published inArthritis & rheumatology, vol. 67, no. 4, p. 1117-1127
Publication date2015
Abstract

To investigate a new therapeutic strategy, with rapid corticosteroid dose tapering and limited cyclophosphamide (CYC) exposure, for older patients with systemic necrotizing vasculitides (SNVs; polyarteritis nodosa [PAN], granulomatosis with polyangiitis [Wegnener's] [GPA], microscopic polyangiitis [MPA], or eosinophilic GPA [Churg-Strauss] [EGPA]).

Keywords
  • Adrenal Cortex Hormones/therapeutic use
  • Aged
  • Aged, 80 and over
  • Azathioprine/therapeutic use
  • Cyclophosphamide/therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Methotrexate/therapeutic use
  • Remission Induction/methods
  • Systemic Vasculitis/drug therapy
  • Treatment Outcome
Citation (ISO format)
PAGNOUX, Christian et al. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. In: Arthritis & rheumatology, 2015, vol. 67, n° 4, p. 1117–1127. doi: 10.1002/art.39011
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN2326-5191
600views
0downloads

Technical informations

Creation11/17/2015 4:17:00 PM
First validation11/17/2015 4:17:00 PM
Update time02/03/2025 11:30:22 AM
Status update02/03/2025 11:30:22 AM
Last indexation02/03/2025 11:38:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack